|
1
|
White NM and Yousef GM: MicroRNAs:
Exploring a new dimension in the pathogenesis of kidney cancer. BMC
Med. 8:652010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schlesinger-Raab A, Treiber U, Zaak D,
Hölzel D and Engel J: Metastatic renal cell carcinoma: Results of a
population-based study with 25 years follow-up. Eur J Cancer.
44:2485–2495. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Moch H: An overview of renal cell cancer:
Pathology and genetics. Semin Cancer Biol. 23:3–9. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hadoux J, Vignot S and De La Motte Rouge
T: Renal cell carcinoma: Focus on safety and efficacy of
temsirolimus. Clin Med Insights Oncol. 4:143–154. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Naito S, Tomita Y, Rha SY, Uemura H, Oya
M, Song HZ, Zhong LH and Wahid MI: Kidney Cancer Working Group
report. Jpn J Clin Oncol. 40 Suppl 1:i51–i56. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sharma P and Allison JP: Immune checkpoint
targeting in cancer therapy: Toward combination strategies with
curative potential. Cell. 161:205–214. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chow TF, Youssef YM, Lianidou E, Romaschin
AD, Honey RJ, Stewart R, Pace KT and Yousef GM: Differential
expression profiling of microRNAs and their potential involvement
in renal cell carcinoma pathogenesis. Clin Biochem. 43:150–158.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Janzen NK, Kim HL, Figlin RA and
Belldegrun AS: Surveillance after radical or partial nephrectomy
for localized renal cell carcinoma and management of recurrent
disease. Urol Clin North Am. 30:843–852. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Filipowicz W, Bhattacharyya SN and
Sonenberg N: Mechanisms of post-transcriptional regulation by
microRNAs: Are the answers in sight? Nat Rev Genet. 9:102–114.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nelson KM and Weiss GJ: MicroRNAs and
cancer: Past, present, and potential future. Mol Cancer Ther.
7:3655–3660. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lin S and Gregory RI: MicroRNA biogenesis
pathways in cancer. Nat Rev Cancer. 15:321–333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Negrini M, Ferracin M, Sabbioni S and
Croce CM: MicroRNAs in human cancer: From research to therapy. J
Cell Sci. 120:1833–1840. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang D, Zhao L, Shen Q, Lv Q, Jin M, Ma
H, Nie X, Zheng X, Huang S, Zhou P, et al: Down-regulation of
KIAA1199/CEMIP by miR-216a suppresses tumor invasion and metastasis
in colorectal cancer. Int J Cancer. 140:2298–2309. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Link A, Becker V, Goel A, Wex T and
Malfertheiner P: Feasibility of fecal microRNAs as novel biomarkers
for pancreatic cancer. PLoS One. 7:e429332012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Miyazaki T, Ikeda K, Sato W, Horie-Inoue
K, Okamoto K and Inoue S: MicroRNA library-based functional
screening identified androgen-sensitive miR-216a as a player in
bicalutamide resistance in prostate cancer. J Clin Med.
21:1853–1865. 2015. View Article : Google Scholar
|
|
19
|
Xia H, Ooi LL and Hui KM:
MicroRNA-216a/217-induced epithelial-mesenchymal transition targets
PTEN and SMAD7 to promote drug resistance and recurrence of liver
cancer. Hepatology. 58:629–641. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Palanichamy JK and Rao DS: miRNA
dysregulation in cancer: Towards a mechanistic understanding. Front
Genet. 5:542014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hou BH, Jian ZX, Cui P, Li SJ, Tian RQ and
Ou JR: miR-216a may inhibit pancreatic tumor growth by targeting
JAK2. FEBS Lett. 589:2224–2232. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang Y, Tang X, Shi M, Wen C and Shen B:
MiR-216a decreases MALAT1 expression, induces G2/M arrest and
apoptosis in pancreatic cancer cells. Biochem Biophys Res Commun.
483:816–822. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen PJ, Yeh SH, Liu WH, Lin CC, Huang HC,
Chen CL, Chen DS and Chen PJ: Androgen pathway stimulates
microRNA-216a transcription to suppress the tumor suppressor in
lung cancer-1 gene in early hepatocarcinogenesis. Hepatology.
56:632–643. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang XX, Deng LH, Chen WW, Shi N, Jin T,
Lin ZQ, Ma Y, Jiang K, Yang XN and Xia Q: Circulating microRNA 216
as a marker for the early identification of severe acute
pancreatitis. Am J Med Sci. 353:178–186. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li Y, Ma W, Xie C, Zhang M, Yin X, Wang F,
Xu J and Shi B: Identification of genes and signaling pathways
associated with diabetic neuropathy using a weighted correlation
network analysis: A consort study. Medicine (Baltimore).
95:e54432016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mansego ML, Garcia-Lacarte M, Milagro FI,
Marti A and Martinez JA: DNA methylation of miRNA coding sequences
putatively associated with childhood obesity. Pediatr Obes.
12:19–27. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Szeto CC, Ching-Ha KB, Ka-Bik L, Mac-Moune
LF, Cheung-Lung CP, Gang W, Kai-Ming C and Kam-Tao LP: Micro-RNA
expression in the urinary sediment of patients with chronic kidney
diseases. Dis Markers. 33:137–144. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Szeto CC: Urine miRNA in nephrotic
syndrome. Clin Chim Acta. 436:308–313. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Barsanti C, Trivella MG, D'Aurizio R, El
Baroudi M, Baumgart M, Groth M, Caruso R, Verde A, Botta L, Cozzi L
and Pitto L: Differential regulation of microRNAs in end-stage
failing hearts is associated with left ventricular assist device
unloading. Biomed Res Int. 2015:5925122015. View Article : Google Scholar : PubMed/NCBI
|
